Abstract
Minerals and trace elements play crucial roles in physiological processes, and alterations in their levels can have significant consequences for metabolic health. This study aimed to investigate serum mineral levels in patients with type 2 diabetes mellitus (T2DM) compared to healthy controls and explore their potential implications for disease pathophysiology. A total of 50 T2DM patients and 30 healthy individuals were included in the study. Serum levels of iron, copper, calcium, magnesium, and zinc were analysed using flame atomic absorption spectrometry. The results revealed significantly higher levels of iron and copper in T2DM patients compared to controls, while lower levels of calcium, magnesium, and zinc were observed in the T2DM group. These findings are consistent with previous research, highlighting the importance of mineral homeostasis in T2DM. Further analysis showed weak interrelationships among the studied minerals in T2DM patients, suggesting complex mechanisms underlying mineral metabolism in the disease. The discussion delved into potential mechanisms contributing to these alterations, including glycosuria-induced urinary loss of zinc and calciuresis due to hyperglycemia. Additionally, the study emphasised the importance of zinc and manganese in insulin production and release, as well as the contradictory findings regarding calcium levels in T2DM. Overall, this study provides valuable insights into serum mineral levels in T2DM and highlights the need for further research to elucidate their roles in disease progression and management.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any external funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee of FEDERAL MEDICAL CENTRE, OWO gave ethical clearance/approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
(fiyinfoluwaajao{at}yahoo.com)
(blessingoyeromi01{at}gmail.com)
Data Availability
All data produced in the present study are available on requests to the authors.
